Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials - Sattar, N; Lee, M MY; Kristensen, S L (Lancet Diabetes Endocrinol, 2021)
et al.